Boditech Med × NICU
Support System
3 Main Challenges in NICU
01
Time matters
Early Detection of Sepsis
Neonatal sepsis can be devastating, leading to high morbidity and mortality in newborns, and is recognized as a global health challenge. Early-onset sepsis is developed from ≤3 days to 7 days and a mortality rate 24.4%. Early detection and treatment of the newborn infant with suspected sepsis are essential to prevent severe and life-threatening complications.
02
Getting it right
Exact diagnosis of Sepsis
Diagnosis of neonatal sepsis is difficult because of the variable and nonspecific clinical presentation. Therefore, many newborns with nonspecific symptoms are started on antibiotic treatment before the presence of sepsis has been proven. Antibiotic abuse is associated with antibiotic resistance, microbiome alterations, and dysbiosis.
03
Track the point
Appropriate antibiotic therapy
Recent reports of neonatal networks show that there are significant practice differences among NICUs related to the initiation of antibiotics in suspected sepsis and also in the duration of antibiotics. The variability among NICUs was surprising and ranged from 10% to 92%. In 5 NICUs, more than 60% of neonates received such management, whereas in 4 NICUs, this was done in fewer than 20% of infants.
Solution
Boditech Med provides the qualitative result of IL-6, PCT, CRP levels, which able to detect rapid and exact detection of infant’s condition.
Using a combination of reliable biomarkers can help to measure more information than single markers.
Interleukin-6
Procalcitonin
C-Reactive
Protein
IL-6 (Interleukin-6)
Interleukin-6 (IL-6) acts as a pro-inflammation cytokine and a key mediator of inflammation. During the acute phase of an infection, B and T lymphocytes are stimulated to produce IL-6 cytokine, which in turn induces hepatocyte production of acute phase reactants such as CRP. As an early phase biomarker, IL-6 has superior sensitivity.
PCT (Procalcitonin)
Procalcitonin (PCT) is the peptide prohormone of calcitonin and an acute phase reactant, independent of calcitonin levels, that is associated with the immunomodulation and vascular response associated with systemic inflammatory response syndrome (SIRS). Produced by monocytes and hepatocytes, concentrations of PCT increase early within 2-4 hours, after an exposure to a bacterial pathogen during the acute stage of sepsis. Levels peak at 6.8 hours and remain elevated for the next 24 hours, with a half –life of 24-30 hours.
CRP (C-Reactive Protein)
Among the acute phase reactants, CRP, produced in the liver, is a frequently used laboratory test for the diagnosis of neonatal sepsis. This biomarker has a half-life of 24-48 hours. CRP can be a reliable late marker for sepsis with changing patterns or continuous decreased levels useful to monitor progress or guide clinicians in decisions related to duration of antibiotic treatment.
Why Boditech Med?
Rotavirus / RSV(respiratory syncytial virus) / Influenza A+B
Norovirus / Adenovirus / Hepatitis B
Mycoplasma / Toxoplasma / TSH
Various test line
for infants
The out braeak database show the 5 most frequent viral agents in INCUs were rotavirus (23.44%), respiratory syncytial virus (17.19%), enterovirus (15.63%), hepatitis A virus (10.94%), and adenovirus (9.38%).
Boditech Med has various panel to prevent nosocomial infection in NICU.
03
Simple and
safe blood collection
The C-tip is a unique invention of Boditech Med Inc. Boditech capillary tip is not only can help to use a small volume of whole blood but also able to test automatic system directly. The simple but accurate tool that minimized neonate or newborn’s pain and risk. It is ideal for multiple blood collections to check the newborn’s condition continuously and decide whether to stop antibiotics.
02
Test Directly in ICU
AFIAS is an In-vitro diagnostic device which is small and compact-size to save ICU space.
An automatic system will help to detect the earliest stage of sepsis at the ICU, anywhere, anytime within 12 minutes.
01
Product detail
-
All-in-one cartridge
-
10, 30 and 50 ul Fingertip blood
-
Fully Automatic system
-
180.6 (L) x 320.6 (W) x 206.4 (H) /mm
-
Automated desktop analyzer
-
6 different tests on 6 different channels
-
Bay random access (2 bays)
-
420 (L) x 336 (W) x 293 (H) /mm
-
QC & system check
-
Multi timer function
-
LIS/HIS connectivity
-
276 (L) x 220 (W) x 91 (H) /mm
-
Continuous testing
-
High-throughput results - up to 100-120 tests/hour
-
Incubation temperature
-
240 (L) x 465 (W) x 341 (H) /mm
Promotion
Laser Lancet giveaway
NICU or clinician who participated in Boditech Med NICU support program will get Laser Lancet giveaway.
HandyRay-Lite (LMT-1000) LAMEDITECH
-For avoid secondary infection
-For pain and phobia
: Less pain than needle lancets that provide no depth adjustments
Boditech Med Inc. pursues its fundamental corporate value 'Respect for Life' with a focus on high quality, user friendliness products. Boditech is making relentless efforts to develop world-class in vitro diagnostics instruments and reagents. The goal is to provide everyone with ssafe and convenient diagnostic products to improve human health and well-bing.
BODITECH MED INC.
43, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gang-won-do 24398, KOREA
T. 82-33-243-1400
F. 82-33-243-9373
Request Catalog
Would you like to receive our
product catalog?
